AKT1 and hepatocellular carcinoma: LncRNA cancer susceptibility 9 (CASC9) interacted with the RNA-binding protein heterogenous nuclear ribonucleoprotein L (HNRNPL), resulting in the activation of the AKT signaling pathway and contributing to increased tumorigenesis by HCC cells [175].